MENDLEIN JOHN

The estimated Net Worth of MENDLEIN JOHN is at least $10 Million dollars dollars as of 10/17/2021. MENDLEIN JOHN is the Director of Fate Therapeutics Inc. MENDLEIN JOHN owns over 156,774 shares of Fate Therapeutics Inc stock worth over $10 Million dollars . MENDLEIN JOHN is the Director of aTyr Pharma Inc. MENDLEIN JOHN owns over 43,956 shares of aTyr Pharma Inc stock worth over $382,856.76.

Insider Roles

Name Transaction Date Position
Fate Therapeutics Inc 2020-05-01 director
aTyr Pharma Inc 2019-05-08 director
Moderna Inc 2018-12-07 officer: See Remarks
Editas Medicine Inc 2017-06-15 director
EMBED
SAVE

MENDLEIN JOHN trading performance

Average Relative Return

-14.67%

Average relative return per transaction

Outperforming Transactions

25%

2 out of 8 outperforming transactions.
Each transaction is measured over a period and compared to .

MENDLEIN JOHN trading performance analysis

1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 18.47 15.19 24.45 -14.67 -57.3 -84.42
Relative Return to S&P 500(%) 15.97 8.78 14.5 -32.11 -79.17 -117.58

Mendlein John trading transactions

Ticker Company Price Insider Name Insider Position Date Buy/Sell Insider Trading Shares Shares Change Price Cost(000) Final Share Price Change Since Insider Trade (%) Dividend Yield % PE Ratio Market Cap ($M)
LIFE
aTyr Pharma Inc
$8.71
MENDLEIN JOHN
Director
2018-12-21 Buy
245,000
66.15%
$0.42
$102.90
43,956.12
1,973.81%
0
At Loss
241.28
LIFE
aTyr Pharma Inc
$8.71
MENDLEIN JOHN
CEO and Director
2017-08-31 Buy
37,736
11.43%
$2.65
$100
26,277.51
228.68%
0
At Loss
241.28
LIFE
aTyr Pharma Inc
$8.71
MENDLEIN JOHN
CEO and Director
2017-04-20 Buy
2,552
0.79%
$3
$7.66
23,394.64
190.33%
0
At Loss
241.28
LIFE
aTyr Pharma Inc
$8.71
MENDLEIN JOHN
CEO and Director
2016-12-19 Buy
69,000
26.96%
$2.20
$151.80
23,212.35
295.91%
0
At Loss
241.28
LIFE
aTyr Pharma Inc
$8.71
MENDLEIN JOHN
CEO and Director
2016-04-05 Buy
2,500
1.02%
$3.55
$8.88
17,748.04
145.35%
0
At Loss
241.28
LIFE
aTyr Pharma Inc
$8.71
MENDLEIN JOHN
CEO and Director
2016-04-05 Buy
2,500
1.01%
$3.52
$8.80
17,926.61
147.44%
0
At Loss
241.28
FATE
Fate Therapeutics Inc
$61.24
MENDLEIN JOHN
Director
2013-10-04 Buy
16,667
11.90%
$6
$100.00
156,774
920.67%
0
At Loss
5,829.10
Total 7
  • 1

MENDLEIN JOHN personal network

Name Position Linked company